Tissue occluding agent comprising an IEIKIEIKIEIKI peptide
US10596225B2 · kind B2 · utility
7Cited by
36References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 4, 2013 |
| Grant date | Mar 24, 2020 |
| Priority date | — |
| Expiry date | Nov 12, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2430/36
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is provided a bioabsorbable peptide tissue occluding agent that can be applied to large mammals including humans, the peptide tissue occluding agent being obtained by artificial synthesis to avoid concerns of infection by viruses and the like. The tissue occluding agent contains a peptide, wherein the peptide is an amphiphilic peptide having 8-200 amino acid residues with the hydrophilic amino acids and hydrophobic amino acids alternately bonded, and is a self-assembling peptide exhibiting a β-structure in aqueous solution in the presence of physiological pH and/or a cation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.